Posted in | News | Iron Ore | Mining Business

Tata Steel Minerals Enters Production Sale Agreement with Iron Ore Company of Canada

New Millennium Iron Corp. announced today that Tata Steel Minerals Canada (“TSMC”), in which NML has a 20% interest, advises that it has entered into a confidential agreement for the sale of TSMC's iron ore production to the Iron Ore Company of Canada (“IOC”). The contract shall allow TSMC to commence shipment of its products in the current year.

Under the confidential sales agreement with IOC, TSMC’s production will be sold by IOC’s marketing organization for delivery to several markets, the details of which will be negotiated between the two parties. In 2012, TSMC produced approximately 300,000 tonnes of 62% Fe direct shipping ore (“DSO”) sinter fines from a portable screening plant. Production resumed in mid-June this year and is expected to continue until October. Meanwhile, construction of the Timmins Processing Plant is progressing and it is now planned to start the plant in November producing DSO grade sinter fines using the crushers and screens and drying for winter shipping. The wet processing and upgrading section of the plant is currently expected to be operational in Q1, 2014. The target is to ship about 2.0 million tonnes in 2013.

Dean Journeaux, President and CEO of NML, said, “This is an important step for NML as we transform ourselves from being a developer to a producer by entering the iron ore market. This interim sales agreement with IOC will enable TSMC to continue production until TSMC can use the new multi-user dock now being constructed by the Port of Sept-Îles at Pointe-Noire, Quebec. We are pleased with the progress of the DSO Project and will continue to work together with TSMC to ensure the completion of plant construction and the continuing transition to a successful production and sales operation.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.